Emmanuel Nursing Home | |
1415 Madison Avenue, Detroit Lakes, Minnesota 56501 | |
(218) 847-4486 | |
Name | Emmanuel Nursing Home |
---|---|
Location | 1415 Madison Avenue, Detroit Lakes, Minnesota |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 102 |
Occupancy Rate | 64.41% |
Medicare ID (CCN) | 245489 |
Legal Business Name | Ecumen |
Ownership Type | Non Profit - Corporation |
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
The Canadian Society of Diagnostic Medical Sonographers (CSDMS) and the Canadian Association of Registered Diagnostic Ultrasound Professionals (CARDUP) are making a presentation to the Ontario Legislative Assembly Standing Committee on Social Policy studying Bill 179 (the Regulated Health Professions Statute Law Amendment Act, 2009).
Acacia Research Corp announced today that a subsidiary has acquired a patent for stent graft technology.
A UK vaccine technology that is set to revolutionise the industry has received £950k funding from the Department for International Development (DFID) to bring to production a pentavalent childhood vaccine that can be stored without refrigeration.
Corcept Therapeutics Incorporated, a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today announced results of a multi-center Phase 1/2 dose-escalation study of mifepristone and chemotherapy drug eribulin (Halaven) that show it is well tolerated and clinically active in patients with triple-negative breast cancer.
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the United Kingdom's National Institute for Health and Clinical Excellence (NICE) has issued final draft guidance indicating that ILUVIEN is not recommended for the treatment of chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
› Verified 2 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 13.48 | 14.46 |
Percentage of long-stay residents who lose too much weight | 7.95 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 45.99 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 6.76 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 4.01 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 1.91 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.53 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.11 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 18.18 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 94.46 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 2.4 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 16.12 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11.17 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 2.53 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 94.57 | 95.98 |
Percentage of short-stay residents who made improvements in function | 82.95 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 89.28 | 82.93 |
News Archive
The Canadian Society of Diagnostic Medical Sonographers (CSDMS) and the Canadian Association of Registered Diagnostic Ultrasound Professionals (CARDUP) are making a presentation to the Ontario Legislative Assembly Standing Committee on Social Policy studying Bill 179 (the Regulated Health Professions Statute Law Amendment Act, 2009).
Acacia Research Corp announced today that a subsidiary has acquired a patent for stent graft technology.
A UK vaccine technology that is set to revolutionise the industry has received £950k funding from the Department for International Development (DFID) to bring to production a pentavalent childhood vaccine that can be stored without refrigeration.
Corcept Therapeutics Incorporated, a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol, today announced results of a multi-center Phase 1/2 dose-escalation study of mifepristone and chemotherapy drug eribulin (Halaven) that show it is well tolerated and clinically active in patients with triple-negative breast cancer.
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the United Kingdom's National Institute for Health and Clinical Excellence (NICE) has issued final draft guidance indicating that ILUVIEN is not recommended for the treatment of chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies.
› Verified 2 days ago
Essentia Health Oak Crossing Location: 1040 Lincoln Avenue, Detroit Lakes, Minnesota 56501 Phone: (218) 844-0700 | |
Emmanuel Nursing Home Location: 1415 Madison Avenue, Detroit Lakes, Minnesota 56501 Phone: (218) 847-4486 |